Dienogest
This paper reviews the pharmacology, pharmacokinetics, efficacy, and safety of dienogest, a progestin used for treating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The provided text for this item contains only bibliographic metadata and a journal citation (Reactions Weekly 2060, 133 (2025)) without any study content describing methods, patient population, results, or conclusions. It does not include any details about what was investigated regarding dienogest, adverse events, or outcomes. No explicit limitations are stated because the actual article text is not available in the prompt. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
681 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (1)
Source provenance
- openalex
- last seen: 2026-05-10T11:10:35.749868+00:00